Association of FGF-2 concentrations with atheroma progression in chronic kidney disease patients
Clinical Journal of the American Society of Nephrology Mar 19, 2018
Bozic M, et al. - This study was designed to determine the role of circulating fibroblast growth factor 2 (FGF-2) levels in the progression of atherosclerosis in CKD. An independent association of low FGF-2 levels with atheromatosis progression was shown in CKD.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
